Prolonged use of antiretroviral therapy (ART) has been associated with dyslipidemia and impaired energy substrate oxidation (SOxi). Curcumin is a natural bioactive compound, which interacts with molecular targets and holds important metabolic properties. The aim of this study was to evaluate the effect of curcumin supplementation on energetic metabolism of an adult female with HIV/AIDS and under ART. The intervention was performed with 500 mg/day of curcumin for 27 days. Glycemic and lipid profile and SOxi at rest were evaluated before and after intervention. 
Prolonged use of antiretroviral therapy (ART) has been associated with dyslipidemia and impaired energy substrate oxidation (SOxi). Curcumin is a natural bioactive compound, which interacts with molecular targets and holds important metabolic properties. The aim of this study was to evaluate the effect of curcumin supplementation on energetic metabolism of an adult female with HIV/AIDS and under ART. The intervention was performed with 500 mg/day of curcumin for 27 days. Glycemic and lipid profile and SOxi at rest were evaluated before and after intervention. After intervention, improvement of lipid profile and insulin sensibility was observed. Moreover, there was a positive modulation of SOxi at rest. Oral curcumin supplementation can positively modulate the energy metabolism of people living with HIV/AIDS using the ART. However, clinical studies are required in order to confirm our findings in a representative sample. However, its prolonged use has been associated with dyslipidemia and impaired substrate oxidation (SOxi), which is characterized by reduction in lipid oxidation and increase in carbohydrate utilization at rest.
Consequently, it leads to insulin resistance and mitochondrial injury (Pérez-Matute, Pérez-Martínez, Blanco, & Oteo, 2013) . Curcumin (Curcuma longa L.) supplementation stands out as a promising strategy to minimize some of the ART side effects, because it has antioxidant, antiinflammatory, antithrombotic, and hepatoprotective effects (Panahi et al., 2016) . Curcumin seems to modulate the expression of genes and the activity of enzymes involved in the lipid homeostasis (Mohammadi et al., 2013) and to have a glucose-lowering effect (Na et al., 2013) .
Moreover, curcumin has important antiviral effects. It inhibits the infection and replication of viral genes, prevents multiplicity of HIV, and enhances the effect of conventional therapeutic drugs (Prasad & Tyagi, 2015) . Thus, the aim of this study was to evaluate the effect of BIOMOR Curcumin® supplementation on glycemic and lipid profile and SOxi at rest of a woman living with HIV/AIDS and under ART.
| CASE PRESENTATION
The study was performed in the Energy Metabolism Laboratory at the The intervention consisted of a supplementation with 500-mg curcumin extracts/day for 27 days. This is an all-natural curcumin supplement with enhanced bioavailability. The manufacturer states that each capsule of BIOMOR Curcumin provides 500 mg of highly absorbable curcumin extract, which is equivalent to as much as 4,000 mg of other curcumin extracts standardized to 95% (Antony et al., 2008) .
The oral curcumin supplement was taken with water after breakfast. Throughout the study, the participant was advised not to change their lifestyle, including diet and physical activity. Follow-up contact occurred throughout the supplementation period. Before and after intervention, the volunteer underwent to blood collection and indirect calorimetry evaluation to perform the biochemical analysis and the SOxi at rest.
The biochemical parameters and the energetic expenditure at rest, before and after curcumin supplementation, are shown in absolute values and through delta variation (% of variation; Table 1 The body fat was evaluated by dual-energy X-ray absorptiometry (Lunar Prodigy Advance, GE Healthcare®). Biochemical analyses were performed by enzymatic/automatized and chemiluminescence methods. Energy expenditure and SOxi at rest were evaluated by indirect calorimetry (Metalyzer 3B, CORTEX®).
| DISCUSSION
The improvement of lipid profile after curcumin supplementation can be explained by curcumin action in specific molecular targets, promoting many benefits, such as inhibition of intestinal absorption of cholesterol, regulation of LDL receptor and enzyme cholesterol 7α-hidroxilase, conversion of cholesterol in bile acids, and fecal excretions of bile acids and cholesterol (Mirzabeigi et al., 2015) . In addition, curcumin facilitates serum-free fat-acids uptake and utilization by the tissues (Na et al., 2013) .
Fasting insulin and homeostasis model assessment of insulinresistance index decreased in 46.8% and 45.1%, respectively (Table 1) .
Inflammation is a key factor in the development of insulin resistance.
Antiinflammatory effect of curcumin may have contributed to improve the insulin sensibility. Curcumin modulates the expression of adiponectin, which suppresses the gluconeogenesis and increases the glucose absorption, by negative regulation of inflammatory cytokines such as TNF-α, IL-6, NF-kB, and COX-2 (Prasad & Tyagi, 2015) . Furthermore, curcumin alters the cell metabolism and signal transduction pathways through AMPK and mTOR enzymes that mediate inflammatory and immunological processes (Lovelace & Polyak, 2015) . Note. HDL-c: HDL cholesterol; LDL-c: LDL cholesterol; REE: resting energy expenditure; TC: total cholesterol; TG: triglycerides.
FIGURE 1 Respiratory quotient (R) during the indirect calorimetry realized before and after oral curcumin supplementation. Before curcumin supplementation, R ranged between 0.85 and 1.0, demonstrating higher utilization of carbohydrates at rest. In contrast, after curcumin supplementation, the peak-to-peak amplitude of R was reduced, remaining in the range of 0.75 to 0.85. This means higher lipid oxidation and better metabolic balance
The positive effect of curcumin on energetic SOxi can be explained by its influence on lipid beta-oxidation and in the reduction of the excess of reactive oxygen species (Na et al., 2013) induced by the HIV and ART (Blas-Garcia, Apostolova, & V Esplugues, 2011) . In a beneficial perspective, curcumin enhances the effect of conventional therapeutic drugs and minimizes their side effects (Prasad & Tyagi, 2015) .
Considering the several metabolic alterations that affect PLHA, it is imperative to study natural dietary compounds capable of modulating the lipid profile and reducing the risk of cardiovascular disease. High levels of circulating free fatty acid are cytotoxic, causing impairment on structure and function of mitochondria and oxidative stress (Rial et al., 2010) . The conventional treatment to dyslipidemia using the statin can cause hepatotoxicity (Chalasani, 2005) , which is a side effect of many ART drugs. Our findings reveal the possibility of using a natural substance (curcumin) to manage dyslipidemia and minimize the side effects of ART and HIV itself, contributing to a better quality of life of PLHA.
Despite the evidence on the benefits of curcumin, studies continue to investigate possible solutions for its low bioavailability, taking into account the right dosages in order to avoid toxicity. Also, there is a need to identify methods for evaluating its activity, determining whether curcumin itself or other components in turmeric are responsible for its effects. Further randomized, double-blind, placebocontrolled human studies are necessary to elucidate conflicting results of the effects of curcumin in humans (Tsuda, 2018) .
| CONCLUSIONS
Oral curcumin supplementation improved the lipid profile and insulin sensibility, as well as modulated positively the energetic substrate oxidation at rest of a PLHA, under the use of ART. Nevertheless, additional clinical studies, including case and control groups, are required to prove our findings in a representative sample.
